Outset Medical’s $76.5 Million Series C Equity Funding

Simpson Thacher is representing Warburg Pincus in connection with a $76.5 million Series C funding round for Outset Medical.

A new investor, funds advised by T. Rowe Price Associates, Inc., led the round, with participation from existing investors including Warburg Pincus.

Outset is a pioneering medical technology company focused on transforming the patient’s care experience as well as finding cost-effective solutions for both patients and providers.

The Simpson Thacher team included Robert Langdon and Mark Myott (M&A); and David Rubinsky and Jeannine McSweeney (ECEB).

Involved fees earner: Robert Langdon – Simpson Thacher & Bartlett; Mark Myott – Simpson Thacher & Bartlett; David Rubinsky – Simpson Thacher & Bartlett; Jeannine McSweeney – Simpson Thacher & Bartlett;

Law Firms: Simpson Thacher & Bartlett;

Clients: Warburg Pincus;


Author: Ambrogio Visconti